Samrat Pharmachem Ltd.

View in App
357.75 +2.90 ▲0.8%

11 December 2023, 04:01:00 PM
Volume: 5,876

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.samratpharmachem.com
Market Cap 110.52 Cr.
Enterprise Value(EV) 130.18 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 5.74 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 62.33 Trailing Twelve Months Ending 2023-09
Industry PE 38.37 Trailing Twelve Months Ending 2023-09
Book Value / Share 204.73 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.75 Calculated using Price: 357.70
Dividend Yield 0.28 Period Ending 2023-03
No. of Shares Subscribed 0.31 Cr. 3,089,700 Shares
FaceValue 10
About Samrat Pharmachem Ltd.
Samrat Pharmachem was incorporated on June 16, 1992, at Ankleshwar in Gujarat. It was promoted by Lalit Mehta & Rajesh Mehta. The company is currently manufacturing iodine salts & bromine salts. The finished products produced by the company are used in various industries like Pharmaceuticals, Chemicals, Food, Fertilizer, Salt, etc. The products of the company are well received in Indian & foreign markets. The company is a public limited company & its shares are listed & traded on the Bombay Stock Exchange & other bourses of India. The company is presently employing 30 people for its operations at Ankleshwar & Mumbai.

Samrat Pharmachem Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Samrat Pharmachem Ltd. Performance

View details >>
1 Day
+0.82%
1 Week
-1.00%
1 Month
-8.15%
3 Month
-11.97%
6 Month
-16.76%
1 Year
-58.82%
2 Year
+50.95%
5 Year
+554.02%
10 Year
+1887.50%

Samrat Pharmachem Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 2.38 2.21 12.07 19.01 7.96 19.10 19.77 44.95 30.25
Return on Capital Employed (%) 6.45 5.31 16.40 23.05 11.80 22.43 23.90 52.33 34.91
Return on Assets (%) 1.10 0.97 4.86 8.37 3.79 8.60 9.22 24.20 16.57

Samrat Pharmachem Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 13 14 15 19 20 24 30 47 63 63
Non Curr. Liab. 1 2 2 1 1 0 0 0 0 1
Curr. Liab. 12 20 19 21 19 34 27 37 53 47
Minority Int.
Equity & Liab. 26 36 36 41 40 58 57 85 116 110
Non Curr. Assets 8 8 8 8 7 9 10 13 18 19
Curr. Assets 18 28 28 33 33 50 47 71 99 92
Misc. Exp. not W/O
Total Assets 26 36 36 41 40 58 57 85 116 110

Samrat Pharmachem Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 48 63 73 93 111 137 179 222 311 291
Other Income 0 0 0 0 0 1 0 1 0 1
Total Income 49 63 73 93 112 138 179 222 311 291
Total Expenditure -47 -62 -69 -87 -108 -131 -170 -198 -287 -286
PBIDT 2 1 4 6 4 7 9 25 24 5
Interest -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Depreciation 0 0 0 0 0 0 0 -1 -1 -1
Taxation 0 0 -1 -2 -1 -2 -2 -6 -6 -1
Exceptional Items 0 0 0
PAT 0 0 2 3 2 4 5 17 17 2
Adjusted EPS 1 1 6 10 5 14 17 56 54 6

Samrat Pharmachem Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 -1 0 -3 0 2 -1 5 17 -9
Cash Fr. Inv. 0 0 -2 1 -2 2 -2 -3 -1 -3
Cash Fr. Finan. -1 0 2 1 2 -4 2 -2 -2 10
Net Change 2 0 0 -1 -1 1 -1 0 14 -3
Cash & Cash Eqvt 2 2 4 2 1 2 0 0 15 12

Samrat Pharmachem Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 49.30 49.65 49.65 49.65 49.54 48.64 48.64 48.64 48.64
Public 50.70 50.35 50.35 50.35 50.46 51.36 51.36 51.36 51.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Samrat Pharmachem Ltd. Announcements

View details >>
Mon, 27 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Duplicate share certificates
Thu, 23 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication - Extract of UFR 30/09/2023
Wed, 08 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting
Approval of Results for the quarter and half year ended September 30 2023

Samrat Pharmachem Ltd. Technical Scans

View details >>
Mon, 11 Dec 2023
High Delivery Percentage High Delivery Percentage
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 1 Year High Decrease in 1 Year
High Increase in 2 Years High Increase in 2 Years

Samrat Pharmachem Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,829.45 1,235.70 +0.0%
Divi's Laboratories Ltd. 97,460.15 3,668.25 -0.4%
Cipla Ltd. 97,091.96 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. 91,293.11 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. 79,752.32 5,544.70 -0.1%
Mankind Pharma Ltd. 76,862.91 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. 70,347.58 2,075.00 +1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 73.18 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 28.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 17.93 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.34 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 59.96 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.73 2,075.00 +1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.98 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 7.69 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 3.91 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.58 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 9.12 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.49 2,075.00 +1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,075.00 +1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,075.00 +1.0%

Samrat Pharmachem Ltd. FAQ's

What is Samrat Pharmachem share price?
Can I buy Samrat Pharmachem shares now?
What is the Dividend Yield of Samrat Pharmachem?
What is the Market Cap of Samrat Pharmachem?
What are the key metrics to analyse Samrat Pharmachem?
What is the 52 Week High and Low of Samrat Pharmachem?
What is the trend of Samrat Pharmachem share price?